Table 2.
Country | Metronidazole | Vancomycin | Macrolides∗ | Moxifloxacin |
---|---|---|---|---|
Germany | 0% | 0% | 75.9% (22/29) | 65.5% (19/29) |
Indonesia | 0% | 0% | 15.2% (5/33) | 24.2% (8/33) |
Ghana | 0% | 0% | 53.3% (8/15) | 0% |
Tanzania | 0% | 0% | 42.9% (3/7) | 0% |
Total | 0% | 0% | 45.2% (38/84) | 32.1% (27/84) |
∗Erythromycin was tested in Germany, Indonesia, and Ghana; Clarithromycin was tested in Tanzania.